December 27, 2019
AuroMedics Pharma is recalling a single lot of gabapentin capsules distributed by Aurobindo Pharma USA. According to the December 25, 2019, US Food and Drug Administration (FDA) Enforcement Report, a losartan-hydrochlorothiazide tablet was discovered in a 1000-count bottle of gabapentin.
The recall affects 100-mg gabapentin capsules (NDC 65682-198-99) from lot 19819029A3 (Exp. 8/21). The product was distributed throughout the United States.
AuroMedics Pharma initiated the voluntary recall November 19, 2019. At press time, the FDA had not yet classified the recall.
Gabapentin is a prescription anticonvulsant used to treat seizures as well as nerve pain associated with shingles.